Vitamin C, Plasma (High-Dose Therapy)
Ordering Recommendation
Use to assess elevated vitamin C concentrations associated with therapeutic intravenous infusion of vitamin C.
New York DOH Approval Status
Specimen Required
Green (sodium or lithium heparin). Place specimen in ice bath immediately. Also acceptable: Plasma separator tube.
Protect from light, centrifuge, transfer plasma, and freeze within 1 hour of collection. Transfer 0.5 mL plasma to an ARUP amber transport tube. (Min: 0.3 mL)
CRITICAL FROZEN AND LIGHT PROTECTED. Separate specimens must be submitted when multiple tests are ordered.
EDTA plasma, whole blood, or body fluids. Grossly hemolyzed specimens.
Thawing and refreezing of the specimen and exposure to light will result in decreased vitamin C concentration.
After separation from cells: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 1 month
Methodology
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-6 days
Reference Interval
Test Number |
Components |
Reference Interval |
---|---|---|
Vitamin C, Plasma | 23-114 µmol/L |
Interpretive Data
Intravenous vitamin C (IVC) administration produces millimolar plasma ascorbate (vitamin C) concentrations. Therapeutic concentrations average 15 mmol/L and range from 1-30 mmol/L. The maximum plasma concentration achieved by oral supplementation of vitamin C is approximately 250 µmol/L.
Vitamin C concentration is reported as micromoles per liter (µmol/L). To convert concentration to millimoles per liter (mmol/L), multiply the result by 0.001.
Laboratory Developed Test (LDT)
Note
Thawing and refreezing of the specimen and exposure to light will result in decreased vitamin C concentration.
Hotline History
Hotline History
CPT Codes
82180
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0080380 | Vitamin C, Plasma | 1903-4 |
Aliases
- Ascorbate
- Intravenous Vitamin C
- IVC